Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorGRIMALDI-BENSOUDA, Lamiae
dc.contributor.authorLE HEUZEY, Jean-Yves
dc.contributor.authorFERRIERES, Jean
dc.contributor.authorLEYS, Didier
dc.contributor.authorDAVY, Jean-Marc
dc.contributor.authorMARTINEZ, Mikel
dc.contributor.authorDIALLA, Olivia
dc.contributor.authorSMADJA, Didier
dc.contributor.authorNIGHOGHOSSIAN, Norbert
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBENICHOU, Jacques
dc.contributor.authorNORDON, Clementine
dc.contributor.authorTOUZE, Emmanuel
dc.contributor.authorABENHAIM, Lucien
dc.contributor.authorSTROKE, P. GRx
dc.contributor.authorGROUPS, P. GRx-Atrial Fibrillation Study
dc.date.accessioned2021-08-30T07:39:47Z
dc.date.available2021-08-30T07:39:47Z
dc.date.issued2021-07-13
dc.identifier.issn0039-2499en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/110238
dc.description.abstractEnBACKGROUND AND PURPOSE: The objective of the study was to assess the effectiveness of individual direct oral anticoagulants versus vitamin K antagonists for primary prevention of stroke (ischemic and hemorrhagic) in routine clinical practice in patients with various clinical risk factors depending on their atrial fibrillation (AF) patterns. METHODS: A nested case-referent study was conducted using data from 2 national registries of patients with stroke and AF. Stroke cases with previous history of AF were matched to up to 2 randomly selected referent patients with AF and no stroke. The association of individual anticoagulant use with ischemic or hemorrhagic stroke was studied in patients with or without permanent AF using multivariable conditional logistic models, controlled for clinically significant risk factors and multiple other cardiovascular risk factors. RESULTS: In total, 2586 stroke cases with previous AF and 4810 nonstroke referent patients with AF were retained for the study. Direct oral anticoagulant users had lower odds of stroke of any type than vitamin K antagonist users: the adjusted-matched OR for ischemic stroke were 0.70 (95% CI, 0.50-0.98) for dabigatran, 0.68 (95% CI, 0.53-0.86) for rivaroxaban, and 0.73 (95% CI, 0.52-1.02) for apixaban while for hemorrhagic stroke they were 0.31 (95% CI, 0.14-0.68), 0.64 (95% CI, 0.39-1.06), and 0.70 (95% CI, 0.33-1.49), respectively. The effects of individual direct oral anticoagulants relative to vitamin K antagonists were similar in permanent AF and nonpermanent AF patients. CONCLUSIONS: Similar results were observed for each direct oral anticoagulant in real life as those observed in the pivotal clinical trials. The pattern of AF did not affect the outcome.
dc.language.isoENen_US
dc.subject.enAnticoagulants
dc.subject.enAtrial fibrillation
dc.subject.enStroke
dc.subject.enEffectiveness
dc.title.enStroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors
dc.typeArticle de revueen_US
dc.identifier.doi10.1161/strokeaha.120.032704en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34253047en_US
bordeaux.journalStrokeen_US
bordeaux.pageStrokeaha120032704en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03328441
hal.version1
hal.date.transferred2021-08-30T07:39:52Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Stroke&rft.date=2021-07-13&rft.spage=Strokeaha120032704&rft.epage=Strokeaha120032704&rft.eissn=0039-2499&rft.issn=0039-2499&rft.au=GRIMALDI-BENSOUDA,%20Lamiae&LE%20HEUZEY,%20Jean-Yves&FERRIERES,%20Jean&LEYS,%20Didier&DAVY,%20Jean-Marc&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record